Acute mixed-lineage leukemia treated with desensitization therapy prior to HLA–haploidentical transplantation with high donor-specific antibodies Kengo KatsukiTakayoshi TachibanaHideaki Nakajima Case Report 27 April 2024
CEBPA mutations in acute myeloid leukemia: implications in risk stratification and treatment Feng-Ming TienHsin-An Hou Progress in Hematology 26 April 2024
Mendelian randomization reveals association of gut microbiota with Henoch–Schönlein purpura and immune thrombocytopenia Chendong JiangShu DengEnwu Yuan Original Article Open access 26 April 2024
Cytomegalovirus infection during daratumumab therapy in patients with newly diagnosed multiple myeloma Taku KikuchiNobuhiro TsukadaTadao Ishida Original Article 19 April 2024
An unfavorable and a successful pregnancy outcome during and after treatment of gamma heavy chain disease Masataka HosoiKazunori UenoTakuro Watanabe Case Report 18 April 2024
JSH practical guidelines for hematological malignancies, 2023: leukemia-2—acute promyelocytic leukemia (APL) Hiroyuki Fujita Guideline 17 April 2024
Bernard–Soulier syndrome caused by a novel GP1BB variant and 22q11.2 deletion Rintaro NagoshiAtsushi SakamotoAkira Ishiguro Case Report 16 April 2024
Honeycomb lung appearance accompanied by pediatric Langerhans cell histiocytosis: changes in imaging findings following chemotherapy Kenichi SakamotoOsamu MiyazakiYoko Shioda Images in Hematology 15 April 2024
Spontaneous regression of multiple solitary plasmacytoma harboring Epstein–Barr virus: a case report and literature review Wataru KitamuraHiroki KobayashiShoichi Kuyama Case Report 15 April 2024
Bispecific antibodies for multiple myeloma: past, present and future Toshiki OchiTatsuya KonishiKatsuto Takenaka Progress in Hematology 13 April 2024
A phase 2, open-label study of ibrutinib plus rituximab in Japanese patients with Waldenstrom’s macroglobulinemia Koji IzutsuHisashi KatoEi Fujikawa Original Article Open access 10 April 2024
Optimized BEAC conditioning regimen improves clinical outcomes of autologous hematopoietic stem cell transplantation in non-Hodgkin lymphomas Sha ZhouJun RaoLi Gao Original Article Open access 08 April 2024
Changes in chronic myeloid leukemia treatment modalities and outcomes after introduction of second-generation tyrosine kinase inhibitors as first-line therapy: a multi-institutional retrospective study by the CML Cooperative Study Group Noriyoshi IriyamaEisaku IwanagaTatsuya Kawaguchi Original Article 08 April 2024
Ex vivo expansion and activation of Vγ9Vδ2 T cells by CELMoDs in combination with zoledronic acid Yusuke InoueAsuka OdaMasahiro Abe Rapid Communication 06 April 2024
Tumor lysis syndrome in induction therapy for acute myeloid leukemia before the rasburicase era Yumiko TodaMasahiro AshizawaYoshinobu Kanda Original Article 05 April 2024
Optimizing random skin biopsies: a review of techniques and indications for intravascular large B-cell lymphoma Naoko EnzanAkihiro KitadateMichihiro Kono Review Article Open access 02 April 2024
Clinical guidelines for prevention and treatment of CAT in Japan and other countries Yoshinobu Seki Progress in Hematology 01 April 2024
Faggot cells observed in a patient with myelodysplastic syndrome with increased blasts Makoto ItoNobuaki Fukushima Images in Hematology 30 March 2024
Efficacy of daratumumab in newly diagnosed multiple myeloma patients with 1q21 gain Hirono IriuchishimaAkio SaitoMorio Matsumoto Original Article 29 March 2024
Primary analysis of a prospective cohort study of Japanese patients with plasma cell neoplasms in the novel drug era (2016–2021) Hirohiko ShibayamaMitsuhiro ItagakiShinsuke Iida Original Article Open access 29 March 2024
A prospective study of zanubrutinib, a Bruton tyrosine kinase inhibitor, in relapsed/refractory idiopathic multicentric Castleman disease Lu ZhangYu-han GaoJian Li Original Article 28 March 2024
Recent advances in understanding the biology of follicular lymphoma Momoko Nishikori Progress in Hematology 27 March 2024
Allogeneic hematopoietic stem cell transplantation after mogamulizumab in T-cell lymphoma patients: a retrospective analysis Mary Jo LechowiczChristy SmithKaren Dwyer Original Article Open access 27 March 2024
Hereditary TTP/Upshaw–Schulman syndrome: the ductus arteriosus controls newborn survival Yoshihiro Fujimura Review Article 27 March 2024
Rapamycin increases leukemia cell sensitivity to chemotherapy by regulating mTORC1 pathway-mediated apoptosis and autophagy Jing XuSiwen ZongZhenjiang Li Original Article 26 March 2024
A phase 1/2 study of NS-87/CPX-351 (cytarabine and daunorubicin liposome) in Japanese patients with high-risk acute myeloid leukemia Kensuke UsukiToshihiro MiyamotoThe Study Group for NS-87/CPX-351 Original Article Open access 26 March 2024
Vitamin B12 deficiency-induced megaloblastic anemia in a pediatric patient with autism spectrum disorder with a chronically unbalanced diet Yuri SawadaKenichi SakamotoChihiro Sawai Case Report 25 March 2024
Sustained remission after cord blood transplantation for breast cancer with lung metastases and myelodysplastic syndrome Naokazu NakamuraNao YamamotoNobuyoshi Arima Case Report 25 March 2024
Aortitis after switching short-acting granulocyte colony-stimulating factors in a lymphoma patient with HLA-B52 Misato TaneHideki KosakoTakashi Sonoki Case Report 23 March 2024
Platelet and large platelet ratios are useful in predicting severity of COVID-19 Hisae SugiharaAtsushi MarumoEriko Morishita Original Article 23 March 2024
Post-marketing surveillance of the safety and effectiveness of nivolumab for classic Hodgkin lymphoma in Japan Akira KawasakiKiyohiko HatakeKensei Tobinai Original Article Open access 23 March 2024
End-of-treatment 18[F]-FDG PET can predict early progression in patients receiving bendamustine-rituximab for follicular lymphoma in first relapse: a prospective West Japan hematology Study Group (W-JHS) NHL01 trial Koji KatoKoji IzutsuJunji Suzumiya Original Article 22 March 2024
Effect of apolipoprotein E (APOE) gene polymorphisms on the lipid profile of children being treated for acute lymphoblastic leukemia Maria IoannidouChrysostomos AvgerosEmmanuel Hatzipantelis Original Article Open access 20 March 2024
Early hematopoietic cell transplantation for familial hemophagocytic lymphohistiocytosis in a regional treatment network in Japan Masataka IshimuraKatsuhide EguchiShouichi Ohga Original Article 20 March 2024
Incidence trends for common subtypes of T-cell lymphoma in Taiwan and the United States from 2008–2020 Chung-I HuangChien-Yu KerYu-Chieh Su Original Article 17 March 2024
Isolated salivary gland extramedullary relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia during blinatumomab treatment Yugo KawakamiMasaru ImamuraChihaya Imai Images in Hematology 16 March 2024
Prognostic model for relapsed/refractory transplant-ineligible diffuse large B-cell lymphoma utilizing the lymphocyte-to-monocyte ratio Daisuke IdeTakahiro FujinoJunya Kuroda Original Article 16 March 2024
Characteristics of chronic lymphocytic leukemia in Japan: Comprehensive analysis of the CLLRSG-01 study Jun TakizawaRitsuro SuzukiJunji Suzumiya Original Article 16 March 2024
Evaluation of the pathogenic potential of germline DDX41 variants in hematopoietic neoplasms using the ACMG/AMP guidelines Hirotaka MatsuiMakoto Hirata Original Article 16 March 2024
A case of Bloom syndrome manifesting with therapy-related myelodysplastic syndromes harboring a novel BLM gene variant Takuma OhashiHiroyoshi KunimotoHideaki Nakajima Case Report 15 March 2024
JSH practical guidelines for hematological malignancies, 2023: I. Leukemia-1. Acute myeloid leukemia (AML) Yoshinobu Maeda Guideline 14 March 2024 Pages: 347 - 373
Analysis of overweight/obese pediatric patients with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 study Hirozumi SanoKeitaro FukushimaDaisuke Tomizawa Original Article 09 March 2024
Prevalence of chromosome 8p11.2 translocations and correlation with myeloid and lymphoid neoplasms associated with FGFR1 abnormalities in a consecutive cohort from nine institutions in Japan Kensuke UsukiTakuro KamedaKazuya Shimoda Original Article Open access 08 March 2024
Correction: Efficacy and safety of ferric citrate hydrate compared with sodium ferrous citrate in Japanese patients with iron deficiency anemia: a randomized, double-blind, phase 3 non-inferiority study Norio KomatsuKojo AritaKoji Hanaki Correction Open access 06 March 2024 Pages: 472 - 472
Numerous osteoclasts and osteoblasts in the bone marrow due to hyperparathyroidism Yi FengTao Wang Images in Hematology 06 March 2024 Pages: 345 - 346
Characteristics and literature review of ETV6::ABL1 fusion gene-positive acute myeloid leukemia Song XueHui-Peng SunXing-Yu Cao Original Article 05 March 2024
Decade-long WT1-specific CTLs induced by WT1 peptide vaccination Tatsuya SuwabeYasuhiko ShibasakiMasayoshi Masuko Original Article 01 March 2024 Pages: 399 - 406
First report of familial mixed phenotype acute leukemia: shared clinical characteristics, Philadelphia translocation, and germline variants Yuka ShiozawaShinya FujitaTakaaki Toyama Case Report 29 February 2024 Pages: 465 - 471
Predictive factors for l-asparaginase hypersensitivity in pediatric acute lymphoblastic leukemia Chane Choed-AmphaiJiraporn KhoranaPimlak Charoenkwan Original Article 29 February 2024 Pages: 442 - 449
